A 10-year single-center audit of cell saver use in cardiac surgery: Single-center audit of cell saver use in cardiac surgery

Michael Otorkpa; Zahid  Mahmood

doi:10.28982/josam.8192

Authors

Michael Otorkpa Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow, United Kingdom https://orcid.org/0009-0000-5890-1651
Zahid Mahmood Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow, United Kingdom https://orcid.org/0009-0008-9707-6947

DOI:

https://doi.org/10.28982/josam.8192

Keywords:

cell saver, cardiac surgery, transfusion

Abstract

Background/Aim: The use of cell saver technology has revolutionized the management of blood in cardiac surgery, with the objective of reducing the need for allogeneic blood transfusions and enhancing patient outcomes. This study presents a 10-year audit of cell saver use in cardiac surgeries at a tertiary cardiothoracic center in Scotland.

Methods: An analysis of data from cardiac surgery cases using cell savers was conducted. The study assessed the quantity of anticoagulant used, the processing of blood, and the recovery of red blood cells.

Results: The center consistently employed heparin as the anticoagulant during the review period. The mean age of the 1717 patients was 56.85 years; 66.86% were male and 33.14% were female. The mean blood processed volume was 1646.55 ml and the mean salvaged red cell volume was 544.22 ml over a 10-year period. The deployment of cell savers was most prevalent during coronary artery bypass graft surgeries and major aortic procedures.

Conclusion: The potential to minimize blood loss and reduce allogeneic blood transfusions is present in cell saver technology for cardiac surgery. The significance of optimizing cell saver protocols to enhance patient care and efficacy is underscored in the study.

Downloads

Download data is not yet available.

References

Sikorski RA, Rizkalla NA, Yang WW, Frank SM. Autologous blood salvage in the era of patient blood management. Vox Sanguinis. 2017 Aug [cited 2025 Jan 17];112(6):499–510.

Li A, Kusuma GD, Driscoll D, Smith N, Wall DM, Levine BL, et al. Advances in automated cell washing and concentration. Cytotherapy. 2021 Sep [cited 2025 Jan 17];23(9):774–86.

Schmidbauer SL, Seyfried TF. Cell salvage at the ICU. JCM. 2022 Jul 2 [cited 2025 Jan 17];11(13):3848.

Vieira SD, Da Cunha Vieira Perini F, De Sousa LCB, Buffolo E, Chaccur P, Arrais M, et al. Autologous blood salvage in cardiac surgery: clinical evaluation, efficacy and levels of residual heparin. Hematology, Transfusion and Cell Therapy. 2021 Jan [cited 2025 Jan 17];43(1):1–8.

Niranjan G, Asimakopoulos G, Karagounis A, Cockerill G, Thompson M, Chandrasekaran V. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial☆. European Journal of Cardio-Thoracic Surgery. 2006 Aug [cited 2025 Jan 17];30(2):271–7.

UK Cell Salvage Action Group. UK Cell Salvage Action Group Intraoperative Cell Salvage: 2022 Survey of Equipment and Practice across the UK in 2019. 2024.

Walunj A, Babb A, Sharpe R. Autologous blood transfusion. Continuing Education in Anaesthesia Critical Care & Pain. 2006 Oct [cited 2025 Jan 17];6(5):192–6.

Vonk ABA, Meesters MI, Garnier RP, Romijn JWA, Van Barneveld LJM, Heymans MW, et al. Intraoperative cell salvage is associated with reduced postoperative blood loss and transfusion requirements in cardiac surgery: a cohort study. Transfusion. 2013 Nov [cited 2025 Jan 17];53(11):2782–9.

Spiess BD. Blood transfusion: the silent epidemic. The Annals of Thoracic Surgery. 2001 Nov [cited 2025 Jan 17];72(5):S1832–7.

Baker RA, Merry AF. Cell salvage is beneficial for all cardiac surgical patients: arguments for and against. J Extra Corpor Technol. 2012 Mar;44(1):P38-41.

Ferraris VA, Ferraris SP, Saha SP, Hessel EA, Haan CK, Royston BD, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the society of thoracic surgeons and the society of cardiovascular anesthesiologists clinical practice guideline. The Annals of Thoracic Surgery. 2007 May [cited 2025 Jan 17];83(5):S27–86.

Surya Akbar TI, Ikhsan M, Dewi RS. Implementation of the blood donation preservation strategy at Indonesian red cross (Irc) blood donor unit (Bdu) Banda Aceh during the COVID-19 pandemic. Bali Med J. 2022 Nov 28 [cited 2025 Jan 17];11(3):1751–4.

Al Khabori M, Al Riyami A, Siddiqi MS, Sarfaraz ZK, Ziadinov E, Al Sabti H. Impact of cell saver during cardiac surgery on blood transfusion requirements: a systematic review and meta‐analysis. Vox Sanguinis. 2019 Aug [cited 2025 Jan 17];114(6):553–65.

Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesthesia & Analgesia. 2009 Aug [cited 2025 Jan 17];109(2):320–30.

Neef V, Vo L, Herrmann E, Triphaus C, Judd L, Winter A, et al. The association between intraoperative cell salvage and red blood cell transfusion in cardiac surgery – an observational study in a patient blood management centre. ait. 2021 [cited 2025 Jan 17];53(1):1–9.

Almeida RMS, Leitão L. The use of cell saver system in cardiac surgery with cardiopulmonary bypass. Revista Brasileira de Cirurgia Cardiovascular. 2013 [cited 2025 Jan 17];28(1):76–82.

Couch BR, Kim E, Shrestha K, Dhanasekara CS, Sabu-Kurian A, Dissanaike SD. Utility of cell saver in trauma compared to cardiac surgery. The American SurgeonTM. 2023 Aug [cited 2025 Jan 17];89(8):3516–8.

Bolliger D, Tanaka KA. More is not always better: effects of cell salvage in cardiac surgery on postoperative fibrinogen concentrations. Journal of Cardiothoracic and Vascular Anesthesia. 2020 Sep [cited 2025 Jan 17];34(9):2383–5.

Luque-Oliveros M. Bacteremia in the red blood cells obtained from the cell saver in patients submitted to heart surgery. Rev Latino-Am Enfermagem. 2020 [cited 2025 Jan 17];28:e3337.

Boulos L, Kuebler JD, Angona R, Sweeney D, Wang H, Nocera E, et al. Cell saver blood reinfusion up to 24 hours post collection in pediatric cardiac surgical patients does not increase incidence of hospital-acquired infections or mortality. J Extra Corpor Technol. 2021 Sep [cited 2025 Jan 17];53(3):161–9.

Chambault AL, Brown LJ, Mellor S, Harky A. Outcomes of cardiac surgery in Jehovah’s Witness patients: A review. Perfusion. 2021 Oct [cited 2025 Jan 17];36(7):661–71.

Mortelmans Y, Vermaut G, Aken HV, Goossens W, Boogaerts M. Quality of washed salvaged red blood cells during total hip replacement: a comparison between the use of heparin and citrate as anticoagulants. Anesthesia & Analgesia. 1994 Aug [cited 2025 Jan 17];79(2):357???363.

Waters JH, Dyga RM, Waters JFR, Yazer MH. The volume of returned red blood cells in a large blood salvage program: where does it all go? (Cme). Transfusion. 2011 Oct [cited 2025 Jan 17];51(10):2126–32.

Cholette JM, Henrichs KF, Alfieris GM, Powers KS, Phipps R, Spinelli SL, et al. Washing red blood cells and platelets transfused in cardiac surgery reduces postoperative inflammation and number of transfusions: Results of a prospective, randomized, controlled clinical trial. Pediatric Critical Care Medicine. 2012 May [cited 2025 Jan 17];13(3):290–9.

Stoneham MD, Barbosa A, Maher K, Douglass P, Desborough MJR, Von Kier S. Intraoperative cell salvage using swab wash and serial thromboelastography in elective abdominal aortic aneurysm surgery involving massive blood loss. Br J Haematol. 2023 Mar [cited 2025 Jan 17];200(5):652–9.